Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$1.07 - $1.55 $23,534 - $34,092
21,995 Added 24.75%
110,859 $138,000
Q1 2023

May 15, 2023

BUY
$0.42 - $1.4 $8,910 - $29,700
21,215 Added 31.36%
88,864 $101,000
Q2 2022

Aug 12, 2022

SELL
$0.63 - $1.22 $2,581 - $4,999
-4,098 Reduced 5.71%
67,649 $44,000
Q1 2022

May 13, 2022

SELL
$0.99 - $2.44 $9,443 - $23,275
-9,539 Reduced 11.74%
71,747 $83,000
Q4 2021

Feb 08, 2022

SELL
$2.18 - $3.93 $640 - $1,155
-294 Reduced 0.36%
81,286 $181,000
Q3 2021

Nov 15, 2021

BUY
$2.71 - $4.35 $319 - $513
118 Added 0.14%
81,580 $243,000
Q2 2021

Aug 13, 2021

SELL
$2.94 - $4.75 $591,507 - $955,666
-201,193 Reduced 71.18%
81,462 $315,000
Q1 2021

May 12, 2021

SELL
$3.99 - $5.53 $113,850 - $157,793
-28,534 Reduced 9.17%
282,655 $1.22 Million
Q4 2020

Feb 11, 2021

SELL
$2.99 - $5.79 $13,356 - $25,863
-4,467 Reduced 1.42%
311,189 $1.21 Million
Q3 2020

Nov 16, 2020

BUY
$4.79 - $9.1 $54,524 - $103,585
11,383 Added 3.74%
315,656 $1.56 Million
Q2 2020

Aug 14, 2020

BUY
$3.61 - $11.84 $198,820 - $652,088
55,075 Added 22.1%
304,273 $2.19 Million
Q1 2020

May 14, 2020

BUY
$2.56 - $6.14 $70,156 - $168,266
27,405 Added 12.36%
249,198 $1.04 Million
Q4 2019

Feb 14, 2020

SELL
$5.78 - $8.11 $4,381 - $6,147
-758 Reduced 0.34%
221,793 $1.31 Million
Q3 2019

Nov 13, 2019

BUY
$6.55 - $9.36 $1.02 Million - $1.46 Million
155,762 Added 233.22%
222,551 $1.84 Million
Q2 2019

Aug 13, 2019

BUY
$5.92 - $9.47 $317,880 - $508,501
53,696 Added 410.11%
66,789 $628,000
Q1 2019

May 13, 2019

BUY
$4.12 - $7.23 $53,943 - $94,662
13,093 New
13,093 $80,000

Others Institutions Holding BSGM

About BioSig Technologies, Inc.


  • Ticker BSGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,814,400
  • Market Cap $60.1M
  • Description
  • BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...
More about BSGM
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.